L. Wildt

9.3k total citations · 1 hit paper
182 papers, 6.3k citations indexed

About

L. Wildt is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Obstetrics and Gynecology. According to data from OpenAlex, L. Wildt has authored 182 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Reproductive Medicine, 73 papers in Public Health, Environmental and Occupational Health and 31 papers in Obstetrics and Gynecology. Recurrent topics in L. Wildt's work include Ovarian function and disorders (64 papers), Reproductive Biology and Fertility (42 papers) and Endometriosis Research and Treatment (34 papers). L. Wildt is often cited by papers focused on Ovarian function and disorders (64 papers), Reproductive Biology and Fertility (42 papers) and Endometriosis Research and Treatment (34 papers). L. Wildt collaborates with scholars based in Germany, Austria and United States. L. Wildt's co-authors include G. Leyendecker, Gary R. Marshall, E. Knobil, Peter B. Licht, Georg Kunz, P. E. Belchetz, G. Mall, D. Beil, H. K. Deininger and James S. Hutchison and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

L. Wildt

166 papers receiving 6.0k citations

Hit Papers

Frequency and Amplitude o... 1981 2026 1996 2011 1981 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
L. Wildt 4.2k 2.1k 1.6k 1.3k 710 182 6.3k
Minoru Irahara 2.5k 0.6× 1.6k 0.7× 625 0.4× 1.0k 0.8× 786 1.1× 318 6.2k
Neri Laufer 4.4k 1.1× 3.6k 1.7× 1.0k 0.7× 1.4k 1.1× 359 0.5× 267 7.4k
Fernando M. Reis 2.7k 0.6× 1.4k 0.7× 2.5k 1.6× 1.2k 1.0× 620 0.9× 253 6.2k
Rui Alberto Ferriani 4.5k 1.1× 2.7k 1.3× 2.1k 1.3× 1.3k 1.1× 640 0.9× 314 6.6k
David R. Meldrum 3.6k 0.9× 2.9k 1.4× 586 0.4× 636 0.5× 1.7k 2.4× 132 6.6k
Vincenzo De Leo 3.1k 0.7× 2.2k 1.0× 591 0.4× 442 0.4× 1.1k 1.5× 213 5.6k
Marco Filicori 4.3k 1.0× 3.0k 1.4× 395 0.3× 377 0.3× 770 1.1× 102 5.3k
M. Yusoff Dawood 1.5k 0.3× 1.6k 0.8× 884 0.6× 571 0.5× 384 0.5× 129 3.8k
Ralf Dittrich 2.4k 0.6× 2.6k 1.2× 439 0.3× 327 0.3× 564 0.8× 251 5.9k
J. Schoemaker 3.4k 0.8× 2.4k 1.1× 328 0.2× 443 0.4× 919 1.3× 159 4.6k

Countries citing papers authored by L. Wildt

Since Specialization
Citations

This map shows the geographic impact of L. Wildt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Wildt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Wildt more than expected).

Fields of papers citing papers by L. Wildt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Wildt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Wildt. The network helps show where L. Wildt may publish in the future.

Co-authorship network of co-authors of L. Wildt

This figure shows the co-authorship network connecting the top 25 collaborators of L. Wildt. A scholar is included among the top collaborators of L. Wildt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Wildt. L. Wildt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saner, Samim, Franko Humer, Wolfgang Moche, et al.. (2018). Occurrence of chemicals with known or suspected endocrine disrupting activity in drinking water, groundwater and surface water, Austria 2017/2018. SHILAP Revista de lepidopterología. 69(3). 155–173. 9 indexed citations
2.
Wildt, L., et al.. (2017). DFP: Ätiologie, Diagnostik und Therapie der Ovarialinsuffizienz - ein Update. Teil 1: Hyperandrogenämische und hypothalamische Ovarialinsuffizienz. 5(6). 335–341.
4.
Rabe, T., Ulrike Blume‐Peytavi, Christian Egarter, et al.. (2015). Hirsutismus – Medikamentöse Therapie Gemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin e.V. und des Berufsverbands der Frauenärzte e.V.. 12(3). 102–149. 1 indexed citations
5.
Wildt, L., et al.. (2012). Ätiologie, Diagnostik und Therapie der Ovarialinsuffizienz - ein Update Teil 2: Hyperprolaktinämische und primäre Ovarialinsuffizienz. 7(2). 106–112. 2 indexed citations
6.
Leyendecker, G. & L. Wildt. (2011). A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Hormone Molecular Biology and Clinical Investigation. 5(2). 125–142. 109 indexed citations
7.
Wildt, L., et al.. (2009). Neue Aspekte in der Diagnostik und Therapie der Hyperprolaktinämie. Journal für Kardiologie (Krause & Pachernegg GmbH). 6(1). 35–38. 1 indexed citations
8.
Urdl, W., et al.. (2009). Karzinomrisiko bei assistierter Reproduktion. Stellungnahme der Österreichischen Gesellschaft für Reproduktionsmedizin und Endokrinologie. Journal für Kardiologie (Krause & Pachernegg GmbH). 6(3). 116–121.
9.
Winkler, K., et al.. (2008). Kinderwunsch nach Chemotherapie - wissenschaftliche Perspektiven und klinische Anwendung. SHILAP Revista de lepidopterología.
10.
Mattle, Verena, et al.. (2007). Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea. Fertility and Sterility. 89(2). 404–409. 15 indexed citations
11.
Wildt, L., et al.. (2006). Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women. Fertility and Sterility. 86(3). 651–657. 19 indexed citations
12.
Mattle, Verena & L. Wildt. (2006). Diagnostik und Therapie der Sterilität. 13(1). 3–24.
13.
Krieg, J.‐C., et al.. (2005). Ätiologie, Physiopathologie, Diagnostik und Therapie der Pubertas tarda bei der Frau. 2(3). 163–172. 1 indexed citations
14.
Dittrich, Ralf, et al.. (1995). Induction of Ovarian Tumors by Endogenous Gonadotropins in Rats Bearing Intrasplenic Ovarian Grafts. Tumor Biology. 16(4). 268–280. 9 indexed citations
15.
Sir‐Petermann, Teresa, et al.. (1989). Der Einfluß von Flutamid auf die pulsatile Gonadotropinsekretion bei Frauen mit Hyperandrogenämie. Archives of Gynecology and Obstetrics. 245(1-4). 993–994. 2 indexed citations
16.
Jäger, Wolfram, Christiane Meier, L. Wildt, Willi Sauerbrei, & Norbert Lang. (1988). CA-125 serum concentrations during the menstrual cycle. Fertility and Sterility. 50(2). 223–227. 36 indexed citations
17.
Adam, R., et al.. (1988). Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer. Archives of Gynecology and Obstetrics. 243(2). 91–99. 9 indexed citations
18.
Jäger, Wolfram, Klaus Diedrich, & L. Wildt. (1987). Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome. Fertility and Sterility. 48(4). 675–678. 55 indexed citations
19.
Braun, P., L. Wildt, & G. Leyendecker. (1983). The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle. Fertility and Sterility. 40(1). 37–44. 13 indexed citations
20.
Leyendecker, G., L. Wildt, H. Gips, W. Nocke, & E. J. Plotz. (1976). Experimental studies on the positive feedback effect of progesterone, 17?-hydroxyprogesterone and 20?-dihydroprogesterone on the pituitary release of LH and FSH in the human female. Archives of Gynecology and Obstetrics. 221(1). 29–45. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026